Stocks · News reference
West Pharmaceutical shares are trading higher after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised its price target from $365 to $400.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Smith+Nephew Launches EVOS PELVIC System to Advance Trauma Care
Smith+Nephew (SNN) launched the EVOS PELVIC Plating System to expand its orthopedic trauma portfolio into pelvic and acetabular fracture management. The system features dedicated plates, cannulated screws, and specialized instruments designed to improve surgical efficiency. The global pelvic trauma market is projected to grow from $2.81 billion in 2025 to $4.79 billion by 2034 at a 6.1% CAGR, driven by increased high-energy fractures and wider adoption of surgical fixation protocols.
Veeva Unveils Falcon Router to Streamline Biopharma Case Routing
Veeva Systems announced the launch of Falcon Router, an AI-powered agentic solution designed to automate the intake and routing of safety, quality, and medical cases for biopharma companies. The solution, available for early adoption in January 2027, will integrate with Veeva's Safety, QMS, and MedInquiry platforms to reduce manual workloads and improve compliance workflows. The announcement reinforces Veeva's AI strategy focused on workflow automation within its Vault ecosystem.